Article

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancers

2020-05-20

Abstract excerpt

<h4>Summary</h4> Synthetic lethal interactions, where the simultaneous but not individual inactivation of two genes is lethal to the cell, have been successfully exploited to treat cancer. GATA3 is frequently mutated in estrogen receptor (ER)-positive breast cancers and its deficiency defines a subset of patients with poor response to hormonal therapy and poor prognosis. However, GATA3 is not targetable. Here we...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dfe4f694-9d77-5017-9f71-b46aab8db0ba
DOI: 10.1101/2020.05.18.101998

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancersDOI 10.1101/2020.05.18.101998Read

GATA3 and MDM2 are synthetic lethal in estrogen receptor-positive breast cancersSemantic proximity Read

Mutant GATA3 Actively Promotes the Growth of Normal and Malignant Mammary Cells.Semantic proximity Read

Gain- and Loss-of-Function Mutations in the Breast Cancer Gene GATA3 Result in Differential Drug SensitivitySemantic proximity Read

The GATA3 X308_Splice breast cancer mutation is a hormone context-dependent oncogenic driverSemantic proximity Read

The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review.Semantic proximity Read

GATA3frameshift mutation promotes tumor growth in human luminal breast cancer cells and induces transcriptional changes seen in primaryGATA3mutant breast cancersSemantic proximity Read

EMP3 negatively modulates breast cancer cell DNA replication, DNA damage repair, and stem-like propertiesSemantic proximity Read

Mutation of GATA3 in human breast tumors.Semantic proximity Read

Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.Semantic proximity Read

MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibitionSemantic proximity Read

The role of MDM2 and MDM4 in breast cancer development and preventionSemantic proximity Read

GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.Semantic proximity Read